
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $410.2M | $662M | $1.2B | $1.3B | $1.5B | |
Revenue Growth (YoY) | 8.3% | 61.41% | 83.3% | 3.54% | 18.03% | |
Cost of Revenues | $288.8M | $477.2M | $801.9M | $796.7M | $944.8M | |
Gross Profit | $121.4M | $184.9M | $411.6M | $459.7M | $538.1M | |
Gross Profit Margin | 29.59% | 27.92% | 33.92% | 36.59% | 36.29% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $22.9M | $28.6M | $94.3M | $97.9M | $134.2M | |
Other Inc / (Exp) | -$1B | $62.7M | $239M | $178.7M | $298.4M | |
Operating Expenses | $127.6M | $131M | $248.5M | $281M | $354.8M | |
Operating Income | -$6.2M | $53.9M | $163.1M | $178.7M | $183.3M | |
Net Interest Expenses | $134.9M | $113.2M | $148.8M | $203.9M | $214.4M | |
EBT. Incl. Unusual Items | -$1.2B | $3.3M | $253.3M | $153.5M | $267.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $968K | $1.9M | $2.6M | -$232.9M | $23M | |
Net Income to Company | -$1.2B | $1.5M | $250.7M | $386.5M | $244.2M | |
Minority Interest in Earnings | -- | -- | -$115.2M | -- | -- | |
Net Income to Common Excl Extra Items | -$1.2B | $1.5M | $135.5M | $386.5M | $244.2M | |
Basic EPS (Cont. Ops) | -- | -- | $1.47 | $5.25 | $1.03 | |
Diluted EPS (Cont. Ops) | -- | -- | $1.47 | $2.52 | $1.02 | |
Weighted Average Basic Share | $37.8M | $37.8M | $41.6M | $51.8M | $59.3M | |
Weighted Average Diluted Share | $37.8M | $37.8M | $41.7M | $146.2M | $60.1M | |
EBITDA | -$807.5M | $350.9M | $653.4M | $634.2M | $801.3M | |
EBIT | -$1B | $107.3M | $393M | $353.2M | $477.1M | |
Revenue (Reported) | $410.2M | $662M | $1.2B | $1.3B | $1.5B | |
Operating Income (Reported) | -$6.2M | $53.9M | $163.1M | $178.7M | $183.3M | |
Operating Income (Adjusted) | -$1B | $107.3M | $393M | $353.2M | $477.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $148.1M | $257.2M | $281M | $341.4M | $443.3M | |
Revenue Growth (YoY) | -- | 73.7% | 9.25% | 21.48% | 29.84% | |
Cost of Revenues | $93M | $181.3M | $184.7M | $227.3M | $316M | |
Gross Profit | $55.1M | $76M | $96.3M | $114.1M | $127.2M | |
Gross Profit Margin | 37.22% | 29.52% | 34.27% | 33.42% | 28.7% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.6M | $22.8M | $27.5M | $34.1M | $37.6M | |
Other Inc / (Exp) | $11.3M | $29.4M | $46.4M | $56.3M | $57.5M | |
Operating Expenses | $23.5M | $56.8M | $68.9M | $83.8M | $108M | |
Operating Income | $31.6M | $19.2M | $27.4M | $30.3M | $19.2M | |
Net Interest Expenses | $24.8M | $26.5M | $69M | $47.4M | $54.9M | |
EBT. Incl. Unusual Items | $18.1M | $22.1M | $4.7M | $39.2M | $21.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $676K | $416K | $3.8M | $2.6M | |
Net Income to Company | $18.1M | $21.4M | $4.3M | $35.4M | $19.3M | |
Minority Interest in Earnings | -- | -$5M | -- | -- | -- | |
Net Income to Common Excl Extra Items | $18.1M | $16.4M | $4.3M | $35.4M | $19.3M | |
Basic EPS (Cont. Ops) | -- | $0.10 | -$0.06 | $0.12 | $0.05 | |
Diluted EPS (Cont. Ops) | -- | $0.10 | -$0.06 | $0.12 | $0.05 | |
Weighted Average Basic Share | $37.8M | $37.4M | $47.6M | $57.9M | $60.2M | |
Weighted Average Diluted Share | $37.8M | $37.4M | $47.8M | $58.4M | $61M | |
EBITDA | $96.1M | $106.5M | $141.4M | $158.6M | $168.2M | |
EBIT | $40.1M | $45.5M | $72.5M | $85M | $75.6M | |
Revenue (Reported) | $148.1M | $257.2M | $281M | $341.4M | $443.3M | |
Operating Income (Reported) | $31.6M | $19.2M | $27.4M | $30.3M | $19.2M | |
Operating Income (Adjusted) | $40.1M | $45.5M | $72.5M | $85M | $75.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $771.2M | $1.2B | $1.3B | $1.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $565.5M | $805.3M | $839.3M | $1B | |
Gross Profit | -- | $205.7M | $432M | $477.5M | $551.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $45.7M | $99M | $104.5M | $137.6M | |
Other Inc / (Exp) | $10.6M | $80.8M | $255.9M | $188.7M | $299.6M | |
Operating Expenses | -- | $164.2M | $260.7M | $295.9M | $379M | |
Operating Income | -- | $41.5M | $171.3M | $181.6M | $172.2M | |
Net Interest Expenses | $50.2M | $115M | $191.3M | $182.2M | $222M | |
EBT. Incl. Unusual Items | -- | $7.3M | $236M | $188M | $249.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $2.5M | $2.4M | -$229.5M | $21.8M | |
Net Income to Company | -- | $4.7M | $233.6M | $417.6M | $228.1M | |
Minority Interest in Earnings | -- | -$5M | -$110.2M | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$258K | $123.4M | $417.6M | $228.1M | |
Basic EPS (Cont. Ops) | -- | $0.10 | $1.30 | $2.44 | $0.95 | |
Diluted EPS (Cont. Ops) | -- | $0.10 | $1.29 | $2.44 | $0.95 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | $361.3M | $688.2M | $651.4M | $810.9M | |
EBIT | -- | $112.7M | $420.1M | $365.7M | $467.7M | |
Revenue (Reported) | -- | $771.2M | $1.2B | $1.3B | $1.6B | |
Operating Income (Reported) | -- | $41.5M | $171.3M | $181.6M | $172.2M | |
Operating Income (Adjusted) | -- | $112.7M | $420.1M | $365.7M | $467.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $148.1M | $257.2M | $281M | $341.4M | $443.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $93M | $181.3M | $184.7M | $227.3M | $316M | |
Gross Profit | $55.1M | $76M | $96.3M | $114.1M | $127.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.6M | $22.8M | $27.5M | $34.1M | $37.6M | |
Other Inc / (Exp) | $11.3M | $29.4M | $46.4M | $56.3M | $57.5M | |
Operating Expenses | $23.5M | $56.8M | $68.9M | $83.8M | $108M | |
Operating Income | $31.6M | $19.2M | $27.4M | $30.3M | $19.2M | |
Net Interest Expenses | $24.8M | $26.5M | $69M | $47.4M | $54.9M | |
EBT. Incl. Unusual Items | $18.1M | $22.1M | $4.7M | $39.2M | $21.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $676K | $416K | $3.8M | $2.6M | |
Net Income to Company | $18.1M | $21.4M | $4.3M | $35.4M | $19.3M | |
Minority Interest in Earnings | -- | -$5M | -- | -- | -- | |
Net Income to Common Excl Extra Items | $18.1M | $16.4M | $4.3M | $35.4M | $19.3M | |
Basic EPS (Cont. Ops) | -- | $0.10 | -$0.06 | $0.12 | $0.05 | |
Diluted EPS (Cont. Ops) | -- | $0.10 | -$0.06 | $0.12 | $0.05 | |
Weighted Average Basic Share | $37.8M | $37.4M | $47.6M | $57.9M | $60.2M | |
Weighted Average Diluted Share | $37.8M | $37.4M | $47.8M | $58.4M | $61M | |
EBITDA | $96.1M | $106.5M | $141.4M | $158.6M | $168.2M | |
EBIT | $40.1M | $45.5M | $72.5M | $85M | $75.6M | |
Revenue (Reported) | $148.1M | $257.2M | $281M | $341.4M | $443.3M | |
Operating Income (Reported) | $31.6M | $19.2M | $27.4M | $30.3M | $19.2M | |
Operating Income (Adjusted) | $40.1M | $45.5M | $72.5M | $85M | $75.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $19.6M | $18.7M | $6.4M | $4.5M | $3.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $91.6M | $178.1M | $204M | $215.7M | $111.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8.5M | $20.7M | $24.5M | $29.3M | $36.7M | |
Total Current Assets | $120.4M | $217.5M | $241.9M | $257.3M | $294.8M | |
Property Plant And Equipment | $1.9B | $1.9B | $2.6B | $2.8B | $3.5B | |
Long-Term Investments | $611.2M | $626.5M | $2.4B | $2.5B | $2.1B | |
Goodwill | -- | -- | $5.1M | $5.1M | $5.1M | |
Other Intangibles | $921.8M | $786M | $695.4M | $591.7M | $652.5M | |
Other Long-Term Assets | $23.6M | -- | -- | -- | -- | |
Total Assets | $3.5B | $3.6B | $5.9B | $6.5B | $6.8B | |
Accounts Payable | $13.4M | $12.2M | $17.9M | $34M | $27.2M | |
Accrued Expenses | $55.9M | $131.3M | $154.4M | $176.8M | $171.2M | |
Current Portion Of Long-Term Debt | $53.3M | $54.3M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $31.8M | $22.8M | $29.2M | $18.7M | |
Other Current Liabilities | $5.6M | $7M | $13.2M | $9.5M | $45.7M | |
Total Current Liabilities | $137.2M | $240.9M | $227.8M | $250.1M | $418.6M | |
Long-Term Debt | $2.3B | $2.3B | $3.4B | $3.6B | $3.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.5B | $2.5B | $3.6B | $3.9B | $3.8B | |
Common Stock | -- | $10K | $14K | $15K | $15K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $1B | $10K | -$839.8M | -$530.8M | -$3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $1B | $3.1B | $3.2B | $6B | |
Total Equity | $1B | $1B | $2.3B | $2.6B | $3B | |
Total Liabilities and Equity | $3.5B | $3.6B | $5.9B | $6.5B | $6.8B | |
Cash and Short Terms | $19.6M | $18.7M | $6.4M | $4.5M | $3.6M | |
Total Debt | $2.4B | $2.3B | $3.4B | $3.6B | $3.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $17.6M | $2M | $9.8M | $8.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $262.6M | $199M | $209.9M | $122.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $28.9M | $31.4M | $27.4M | $32.5M | |
Total Current Assets | -- | $309.5M | $246.2M | $257.3M | $315M | |
Property Plant And Equipment | -- | $2.5B | $2.7B | $2.8B | $3.7B | |
Long-Term Investments | -- | $2.4B | $2.4B | $2.5B | $2.1B | |
Goodwill | -- | $3.9M | $5.1M | $5.1M | $5.1M | |
Other Intangibles | -- | $773M | $676.5M | $562.8M | $633.8M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $6B | $6.1B | $6.4B | $7B | |
Accounts Payable | -- | $10.9M | $18.3M | $16.5M | $38.7M | |
Accrued Expenses | -- | $203.1M | $170.5M | $163.5M | $223.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $33M | $39.8M | $25M | $15.8M | |
Other Current Liabilities | -- | $73.1M | $13.9M | $22.4M | $38.3M | |
Total Current Liabilities | -- | $388.6M | $248.3M | $234M | $475.3M | |
Long-Term Debt | -- | $2.9B | $3.5B | $3.5B | $3.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $3.5B | $3.8B | $3.8B | $4.1B | |
Common Stock | -- | $7K | $14K | $15K | $15K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -$60.7M | -- | -- | -- | |
Minority Interest, Total | -- | $3.6B | $2.9B | $3.6B | $5.5B | |
Total Equity | -- | $2.5B | $2.3B | $2.7B | $2.9B | |
Total Liabilities and Equity | -- | $6B | $6.1B | $6.4B | $7B | |
Cash and Short Terms | -- | $17.6M | $2M | $9.8M | $8.8M | |
Total Debt | -- | $2.9B | $3.5B | $3.5B | $3.7B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.2B | $1.5M | $250.7M | $386.5M | $244.2M | |
Depreciation & Amoritzation | $223.8M | $243.6M | $260.3M | $281M | $324.2M | |
Stock-Based Compensation | -- | -- | $42.8M | $56M | $76.5M | |
Change in Accounts Receivable | -$7.3M | -$88.5M | -$8.3M | -$12.1M | -$7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $102.1M | $235.6M | $613M | $584.5M | $637.3M | |
Capital Expenditures | $199.1M | $82.7M | $221.6M | $329.6M | $275.9M | |
Cash Acquisitions | -$306.5M | -$16.9M | -$64.8M | -$363.8M | $94.5M | |
Cash From Investing | -$505.6M | -$99.6M | -$286.1M | -$686.3M | -$176.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$41.1M | -$81.4M | -$175.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $375.6M | $68.7M | $3.6B | $1.6B | $1.2B | |
Long-Term Debt Repaid | -$203.9M | -$166M | -$3.2B | -$1.4B | -$1.3B | |
Repurchase of Common Stock | -- | -- | -- | -$5.8M | -- | |
Other Financing Activities | $201M | -$39.5M | -$689.9M | -$11.9M | -$222.4M | |
Cash From Financing | $372.8M | -$136.8M | -$339.2M | $100M | -$461.4M | |
Beginning Cash (CF) | $50.3M | $19.6M | $18.7M | $6.4M | $4.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$30.7M | -$862K | -$12.3M | -$1.9M | -$904K | |
Ending Cash (CF) | $19.6M | $18.7M | $6.4M | $4.5M | $3.6M | |
Levered Free Cash Flow | -$97M | $152.9M | $391.4M | $254.9M | $361.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.1M | $21.4M | $4.3M | $35.4M | $19.3M | |
Depreciation & Amoritzation | $56M | $61M | $68.9M | $73.6M | $92.7M | |
Stock-Based Compensation | -- | $6.1M | $17.5M | $22.6M | $20.7M | |
Change in Accounts Receivable | -$69.4M | -$67.4M | $5M | $5.8M | -$19.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $41.6M | $98.4M | $119.6M | $153.7M | $176.8M | |
Capital Expenditures | $20.5M | $32.8M | $68.6M | $60.2M | $81.5M | |
Cash Acquisitions | -$20.5M | $13.4M | -$183.6M | -$3M | -$179.2M | |
Cash From Investing | -$41.1M | -$19.4M | -$246.5M | -$62M | -$260.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$16.9M | -$38.7M | -$47M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $41.7M | $7M | $267M | $44M | $647.2M | |
Long-Term Debt Repaid | -$12.4M | -$26.4M | -$125M | -$91M | -$433M | |
Repurchase of Common Stock | -- | -$60.7M | -$2.4M | -- | -- | |
Other Financing Activities | -$18.5M | -- | -$174K | -$732K | -$78.7M | |
Cash From Financing | $10.8M | -$80.1M | $122.5M | -$86.5M | $88.5M | |
Beginning Cash (CF) | $19.6M | $18.7M | $6.4M | $4.5M | $3.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.3M | -$1.1M | -$4.4M | $5.2M | $5.2M | |
Ending Cash (CF) | $30.9M | $17.6M | $2M | $9.8M | $8.8M | |
Levered Free Cash Flow | $21.1M | $65.6M | $51M | $93.5M | $95.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $4.7M | $233.6M | $417.6M | $228.1M | |
Depreciation & Amoritzation | -- | $248.6M | $268.2M | $285.7M | $343.3M | |
Stock-Based Compensation | -- | $6.1M | $54.2M | $61M | $74.6M | |
Change in Accounts Receivable | -- | -$86.6M | $64.1M | -$11.3M | -$32.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $292.4M | $634.2M | $618.6M | $660.5M | |
Capital Expenditures | $20.5M | $95M | $257.4M | $321.1M | $297.2M | |
Cash Acquisitions | -$20.5M | $17M | -$261.8M | -$183.2M | -$81.7M | |
Cash From Investing | -- | -$78M | -$513.2M | -$501.8M | -$375M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$58.1M | -$103.2M | -$183.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $34M | $3.8B | $1.3B | $1.8B | |
Long-Term Debt Repaid | -- | -$180M | -$3.3B | -$1.3B | -$1.6B | |
Repurchase of Common Stock | -- | -- | $58.3M | -$3.3M | -- | |
Other Financing Activities | -- | -- | -$690.1M | -$12.5M | -$300.3M | |
Cash From Financing | -- | -$227.7M | -$136.7M | -$109M | -$286.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$13.3M | -$15.7M | $7.8M | -$911K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $197.4M | $376.8M | $297.5M | $363.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.1M | $21.4M | $4.3M | $35.4M | $19.3M | |
Depreciation & Amoritzation | $56M | $61M | $68.9M | $73.6M | $92.7M | |
Stock-Based Compensation | -- | $6.1M | $17.5M | $22.6M | $20.7M | |
Change in Accounts Receivable | -$69.4M | -$67.4M | $5M | $5.8M | -$19.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $41.6M | $98.4M | $119.6M | $153.7M | $176.8M | |
Capital Expenditures | $20.5M | $32.8M | $68.6M | $60.2M | $81.5M | |
Cash Acquisitions | -$20.5M | $13.4M | -$183.6M | -$3M | -$179.2M | |
Cash From Investing | -$41.1M | -$19.4M | -$246.5M | -$62M | -$260.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$16.9M | -$38.7M | -$47M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $41.7M | $7M | $267M | $44M | $647.2M | |
Long-Term Debt Repaid | -$12.4M | -$26.4M | -$125M | -$91M | -$433M | |
Repurchase of Common Stock | -- | -$60.7M | -$2.4M | -- | -- | |
Other Financing Activities | -$18.5M | -- | -$174K | -$732K | -$78.7M | |
Cash From Financing | $10.8M | -$80.1M | $122.5M | -$86.5M | $88.5M | |
Beginning Cash (CF) | $19.6M | $18.7M | $6.4M | $4.5M | $3.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.3M | -$1.1M | -$4.4M | $5.2M | $5.2M | |
Ending Cash (CF) | $30.9M | $17.6M | $2M | $9.8M | $8.8M | |
Levered Free Cash Flow | $21.1M | $65.6M | $51M | $93.5M | $95.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.